LexAurum Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Buy |
789
+22
| +3% | +$8.92K | 0.05% | 261 |
|
|
2025
Q1 | $381K | Buy |
767
+3
| +0.4% | +$1.49K | 0.07% | 227 |
|
|
2024
Q4 | $398K | Buy |
764
+159
| +26% | +$82.8K | 0.08% | 211 |
|
|
2024
Q3 | $374K | Hold |
605
| – | – | 0.08% | 205 |
|
|
2024
Q2 | $335K | Hold |
605
| – | – | 0.08% | 208 |
|
|
2024
Q1 | $351K | Hold |
605
| – | – | 0.09% | 200 |
|
|
2023
Q4 | $321K | Buy |
605
+1
| +0.2% | +$530 | 0.08% | 214 |
|
|
2023
Q3 | $306K | Hold |
604
| – | – | 0.09% | 211 |
|
|
2023
Q2 | $315K | Hold |
604
| – | – | 0.09% | 192 |
|
|
2023
Q1 | $348K | Sell |
604
-152
| -20% | -$87.6K | 0.12% | 163 |
|
|
2022
Q4 | $416K | Hold |
756
| – | – | 0.15% | 140 |
|
|
2022
Q3 | $383K | Hold |
756
| – | – | 0.15% | 148 |
|
|
2022
Q2 | $411K | Buy |
756
+3
| +0.4% | +$1.63K | 0.15% | 137 |
|
|
2022
Q1 | $445K | Hold |
753
| – | – | 0.15% | 141 |
|
|
2021
Q4 | $502K | Sell |
753
-8
| -1% | -$5.33K | 0.16% | 138 |
|
|
2021
Q3 | $435K | Buy |
761
+8
| +1% | +$4.57K | 0.13% | 180 |
|
|
2021
Q2 | $380K | Hold |
753
| – | – | 0.11% | 198 |
|
|
2021
Q1 | $343K | Buy |
753
+1
| +0.1% | +$456 | 0.12% | 184 |
|
|
2020
Q4 | $350K | Hold |
752
| – | – | 0.13% | 173 |
|
|
2020
Q3 | $332K | Hold |
752
| – | – | 0.14% | 152 |
|
|
2020
Q2 | $273K | Hold |
752
| – | – | 0.15% | 153 |
|
|
2020
Q1 | $213K | Hold |
752
| – | – | 0.15% | 159 |
|
|
2019
Q4 | $244K | Buy |
+752
| New | +$244K | 0.12% | 177 |
|